Stay updated on Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page
- Check7 days agoChange DetectedThe site revision label was updated from v3.5.4 to v3.5.5, signaling a new version of the page template. No study-specific content or functionality changes are indicated.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision tag has been updated to Revision: v3.5.4, replacing the previous v3.5.3. This indicates a new version of the page in the site's revision history.SummaryDifference0.0%

- Check43 days agoChange DetectedUpdated the location entry from Malmo, Sweden, 20502 to Malmö, Sweden, 20502 to reflect the correct spelling of the city name.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page’s revision/version label has been incremented from v3.5.2 to v3.5.3, indicating a site/update release rather than any change to the study information.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision tag updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.0%

- Check86 days agoChange DetectedRevision tag updated: v3.5.0 added and the previous v3.4.3 removed.SummaryDifference0.0%

Stay in the know with updates to Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.